Notícias

BACKGROUND

The oral protease inhibitor nirmatrelvir has shown substantial efficacy in high-risk, unvaccinated patients infected with the B.1.617.2 (delta) variant...

he coronavirus disease 2019 (Covid-19) pandemic has claimed an estimated 15 million lives, including more than 1 million lives in...

EMS Rally Team, que leva nome do laboratório, irá competir nas categorias UTV2 e UTV3; 30ª edição acontece a partir...

Introduction

Since its emergence, there have been huge efforts to design vaccines against coronavirus disease 2019 (COVID-19) to inhibit its...

Acompanhe as atualizações! 

Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks

24 August 2022 –...

ABIFINA participou de grupos técnicos que identificaram desafios e soluções para as Parcerias para o Desenvolvimento Produtivo

O Ministério da...

Abstract

Background

Abstract

Background: 

Remdesivir (RDV) is the main antiviral for the treatment of moderate to severe forms of Coronavirus disease 2019...

Abstract

Background

More than 2.7 million hospitalizations of COVID-19-infected patients have occurred in Europe alone since the outbreak of the...

Abstract

BACKGROUND

Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an important component of the comprehensive response to...

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerged throughout the world,...

Background: A new strain of a novel disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been recently...